search
FDA
Trends
- 1E. coli outbreak linked to raw milk cheese sickens 13 across USโE. coli outbreak linked to raw milk cheese leads to 13 illnesses and eight hospitalizations across the US: FDA
Federal health officials are investigating an E. coli outbreak tied to raw milk cheese that has sickened 13 people across the United States, according to the FDA. Eight of those affected required hospitalization. The agency has not detailed which cheese products or brands are involved, and consumers are being advised to watch for updates as the investigation continues.
- 2
The FDA has announced a recall of raw milk cheese linked to an E. coli outbreak. Multiple US news outlets, including DC News Now, WTNH and NewsNation, are reporting the recall, which affects consumers who may have purchased the cheese. Health officials typically urge anyone with symptoms of E. coli infection, such as severe stomach cramps and diarrhea, to seek medical attention. Further details about the brand and affected states have not been provided in early reports.
- 3Cyclosporiasis outbreak tied to shredded lettuce at Taco BellโCyclosporiasis outbreak linked to shredded lettuce served at some Taco Bell locations: CDC, FDA
Federal health authorities have linked an outbreak of cyclosporiasis, an intestinal illness caused by a parasite, to shredded lettuce served at some Taco Bell locations. The CDC and FDA are investigating the cases, and the fast-food chain is drawing scrutiny as the affected lettuce supply raises food safety concerns for customers and regulators alike.
- 4CDC and FDA link E. coli outbreak to raw milk cheese brandโผE. coli outbreak linked to raw milk cheese brand: CDC, FDA
Federal health agencies are investigating an E. coli outbreak that has been linked to a raw milk cheese brand. The CDC and FDA have identified the cheese as the likely source of the infections. Raw milk products carry a higher risk of bacterial contamination because they are not pasteurized, and officials typically urge consumers to avoid affected products while the investigation continues.
- 5FDA links Ecuadorian black clams to hepatitis A outbreakโFDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalized
The FDA is warning consumers about black clams imported from Ecuador after they were tied to an outbreak of hepatitis A that has left 30 people hospitalized. Health officials are urging anyone who may have eaten the clams to watch for symptoms such as jaundice, fatigue and abdominal pain, and investigators are working to trace the contaminated shellfish and prevent further sales.
- 6Thyroid medicine recall flagged as FDA's highest riskโThyroid medicine recall classified under FDA's highest risk level https:// blog.taursnd.haus/display/1a04 1b09-206a-b7ca
A thyroid medication has been recalled and the recall has been classified at the FDA's most serious risk level, meaning the agency considers the issue potentially life-threatening. The announcement is drawing attention as patients who rely on thyroid medicine are urged to check whether their supply is affected and follow FDA guidance on returning or replacing it.
- 7
Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.
- 8
Disc Medicine, a clinical-stage biotech company, is facing investor investigations following an FDA letter that raised concerns for shareholders. Law firms have reportedly begun looking into whether the company misled investors about its regulatory prospects. The development puts pressure on the stock and adds uncertainty to the company's drug approval timeline, drawing attention from biotech investors tracking FDA-related setbacks.
- 9FDA Issues New Guidance For Surgical Robot MakersโNew FDA Guidance Opens A Common Playbook For Surgical Robot Makers
The FDA has released new guidance establishing a common playbook for companies developing surgical robots. The framework is expected to give robotic surgery manufacturers a clearer, more consistent path through regulatory review. Industry watchers say it could lower barriers for new entrants and speed approval of next-generation surgical robotics systems across the market.